Related Experiment Videos
[Infantile scleroderma. Apropos of 11 cases]
J Goldenberg1, A Pinto-Pessoa, M Odete-Hilario
1Escola Paulista de Medicina, Disciplina de Reumatologia, São Paulo, Brésil.
Summary
Scleroderma is rare in pediatric patients, with only 84 cases previously reported. A new study of 11 pediatric scleroderma cases shows a good prognosis with no deaths or significant organ damage.
Area of Science:
- Pediatric rheumatology
- Dermatology
- Autoimmune diseases
Context:
- Scleroderma is an uncommon autoimmune condition affecting connective tissues.
- Limited data exists on pediatric scleroderma cases, with only 84 reported globally.
- This study examines a new cohort of 11 pediatric patients.
Purpose:
- To describe the clinical features and disease course of scleroderma in children and adolescents.
- To assess the prognosis and outcomes of pediatric scleroderma.
- To contribute to the understanding of this rare condition in a young population.
Summary:
- Eleven new cases of childhood scleroderma were analyzed.
- The study details the clinical presentation and progression of the disease.
- Key findings indicate a favorable prognosis, with no mortality or significant visceral involvement.
Impact:
- Provides valuable insights into the clinical spectrum of pediatric scleroderma.
- Highlights the generally good prognosis for children diagnosed with this condition.
- Informs clinical management and patient counseling for pediatric scleroderma.